Back to Search
ARIE SALZMAN, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1467490466IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
L0921(TX)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
OTHER
Class of 1993
Research & Publications (20)
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injury.
PMID 19174745·Shock·2009
7-preclinical
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial.
PMID 18535785·J Thromb Thrombolysis·2009
4-observational
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
PMID 18562629·J Endocrinol·2008
7-preclinical
Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity.
PMID 18951875·Biochem Biophys Res Commun·2008
7-preclinical
Short-term effects of glipizide (an adenosine triphosphate-sensitive potassium channel inhibitor) on cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep.
PMID 17047524·Shock·2006
7-preclinical
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
PMID 16170028·Mol Cancer Ther·2005
7-preclinical
Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
PMID 16078828·J Med Chem·2005
8-other
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
PMID 15793205·Diabetes Care·2005
4-observational
Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c]isoquinolin- 5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one.
PMID 15844898·Org Lett·2005
8-other
Nebulized nitric oxide/nucleophile adduct reduces pulmonary vascular resistance in mechanically ventilated septicemic sheep.
PMID 15753755·Crit Care Med·2005
7-preclinical
Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection.
PMID 15942694·Int J Mol Med·2005
7-preclinical
The ATP-sensitive potassium-channel inhibitor glibenclamide improves outcome in an ovine model of hemorrhagic shock.
PMID 15377897·Shock·2004
7-preclinical
Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury.
PMID 15539128·J Heart Lung Transplant·2004
7-preclinical
Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
PMID 15312830·J Heart Lung Transplant·2004
4-observational
Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
PMID 15172241·Ann Thorac Surg·2004
7-preclinical
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
PMID 14752285·Shock·2004
7-preclinical
Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.
PMID 14767566·Int J Mol Med·2004
7-preclinical
The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
PMID 15028959·Pancreas·2004
7-preclinical
Cytokines stimulate expression of inducible nitric oxide synthase in DLD-1 human adenocarcinoma cells by activating poly(A) polymerase.
PMID 15693609·Inflamm Res·2004
8-other
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
PMID 14684303·Bioorg Med Chem Lett·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1710 E SAUNDERS, SUITE B670
LAREDO, TX 78041 - Phone
- (956) 795-8275
Quick Facts
- NPI
- 1467490466
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile